- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Ethan Zohn doing well on Adcetris
According to a profile in People magazine, Survivor winner Ethan Zohn is doing well on Adcetris (SGN-35), the treatment he's receiving for relapsed Hodgkin's lymphoma.
After three rounds of the treatment, Zohn said "I'm responding very well to the drug. My tumors are reducing. It's not a 100-percent reduction, but my doctor gave me an A-minus so I'll take it."
Zohn ran the New York City Marathon in November, finishing in 4 hours 20 minutes, and more recently ran the Walt Disney World Half Marathon. Next he intends to take part in a cycling event to raise money for the Memorial Sloan-Kettering Cancer Center in New York.
Eventually Zohn will be tested for a possible stem-cell transplant.